Nasal COVID-19 vaccine to enter US clinical trials
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
WBBM Radio Chicago on MSN8h
Mayor’s office rescinds COVID-19 vaccine mandate, ‘2 years too late’: police union president
The Fraternal Order of Police has been fighting the requirement since the Lightfoot administration imposed it in 2021.
Time on MSN7d
RFK Jr. Says He Doesn’t Know if COVID-19 Vaccines Work
R obert F. Kennedy Jr., President Trump’s pick to head the U.S. Department of Health and Human Services (HHS), was grilled by ...
La Crosse Tribune6d
Development of an mRNA vaccine for Covid-19 was fast
Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...
CNN on MSN13d
NIH interim director comes from its research ranks but is known for questioning Covid-19 vaccine mandates
Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...
What Has RFK Jr. Said About Covid-19?
Citing unverified data, Robert F. Kennedy Jr. claimed in December 2021 that the Covid-19 vaccine was the “deadliest vaccine ...
thecardiologyadvisor.com3d
COVID-19 Vaccine Confers Protection Against Post-COVID-19 Conditions
The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.
psychiatryadvisor.com1d
Interviews ID Factors Tied to COVID-19 Vaccine Hesitancy in Black Women
(HealthDay News) — Three main themes may largely explain COVID-19 vaccine hesitancy among Black women in the United States: mistrust in health care and government, concerns over vaccine safety, and ...
The Hill on MSN10d
Trump to reinstate military members dismissed over COVID-19 shot refusal
Service members dismissed from the military for failing to get vaccinated against COVID-19 will be reinstated with full back ...
EurekAlert!2d
Nasal COVID-19 vaccine based on WashU technology to enter US clinical trials
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...